Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

NRIXNRIX
Showing 8 of 24 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in NURIX THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 2.5M shares of NRIX (NURIX THERAPEUTICS INC), worth $61.6M as of 2026-Q2. The position was increased (+0.7% shares). NRIX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$61.6M

Current Shares

2.5M

Total Value Change

+$29M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.5M
+0.7%
$61.6M0.0%$24.26
30
2026-Q1
Increased
2.5M
+5.7%
$39.1M0.0%$15.81
31
2025-Q4
Increased
2.4M
+26.7%
$45.3M0.0%$19.02
36
2025-Q3
Increased
1.9M
+0.0%
$17.4M0.0%$9.28
28
2025-Q2
Increased
1.9M
+9.1%
$21.4M0.0%$11.64
31
2025-Q1
Increased
1.7M
+8.8%
$20.5M0.0%$12.15
31
2024-Q4
Increased
1.6M
+9.5%
$29.9M0.0%$18.64
32
2024-Q3
Increased
1.4M
+9.6%
$32.5M0.0%$23.05
32

Other major holders of NRIX: BlackRock, Inc., FMR LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used